drug
as of 2026-07-01repetitive Transcranial Magnetic Stimulation(Magstim rapid2)
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by University of Tehran
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Investigational (via trials)
Trials
1
Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia
NCT01315587Phase 2Unknown
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication